29.02.2024 • News
ICL Acquires Brazilian Biologicals Specialist Nitro 1000
ICL is to acquired Nitro 1000, a Brazilian manufacturer, developer and provider of biologicals for approximately $30 million.
Mergers & Acquisitions (M&A)
23.02.2024 • News
AstraZeneca Completes Acquisitions of Gracell and Icosavax
Within a few days, Anglo-Swedish drugmaker AstraZeneca has completed the acquisitions of Gracell Biotechnologies and Icosavax. Both transactions were announced in December 2023.
22.02.2024 • News
NextChem to Buy Electrochemical Firms HyDEP and Dragoni Group
NextChem, part of Italian engineering group Maire Tecnimont, has signed a binding agreement to acquire 80% of HyDEP and 100% of Dragoni Group for a total of approximately €3.6 million.
21.02.2024 • News
LyondellBasell Buys Mechanical Recycling Assets in California
Olefins and polyolefins giant LyondellBasell (LYB) has acquired mechanical recycling assets containing rigid plastics recycling processing lines in the US from PreZero, a recycling and waste management service provider. The transaction, LYB said, includes the lease of the processing facility in Jurupa Valley, California, with a production capacity of approx. 23 million kg/year for recycled materials.
13.02.2024 • News
Gilead to Buy Liver Drugmaker CymaBay for $4.3 Billion
US biopharmaceutical company Gilead Sciences is to acquire CymaBay Therapeutics for $4.3 billion. Gilead offered to purchase all outstanding shares of CymaBay for $32.50 per share in cash.
13.02.2024 • News
Viridor Takes Full Ownership of Norwegian Chemical Recycler Quantafuel
UK-based recycling and waste management company Viridor has closed the acquisition of Norwegian chemical recycler Quantafuel as the Oslo Stock Exchange delisted Quantafuel’s shares from Euronext Growth on Feb. 7.
08.02.2024 • News
Novo Holdings to Acquire Catalent for $16.5 Billion
Novo Holdings, Novo Nordisk's parent company, is acquiring US contract development and manufacturing organization (CDMO) Catalent for $16.5 billion. The companies said that Novo Holdings will acquire all outstanding shares of Catalent for $63.50 per share in cash.
08.02.2024 • News
Brenntag Acquires a Chemical Logistics Site in Italy
Brenntag announced the agreement to acquire a chemical logistics site of Chimica D’Agostino in Italy. The site is located in the industrial area of the city of Bari, well connected with Adriatic highway, and with easy access to harbours on the seaside.
07.02.2024 • News
MSD Animal Health to Acquire Elanco’s Aqua Business
MSD Animal Health, a division of Merck & Co., announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for €1.2 billion ($1.3 billion) in cash. The acquisition is expected to be completed by mid-year 2024, subject to approvals from regulatory authorities and other customary closing conditions.
02.02.2024 • News
Teva Intends to Divest API Business
Israeli generics manufacturer Teva Pharmaceuticals intends to divest its active pharmaceutical ingredient (API) business, Teva API (TAPI). A standalone business unit of Teva, TAPI supplies APIs to over 1,000 customers worldwide and has approximately 4,300 employees worldwide.
01.02.2024 • News
OMV to Divest Upstream Gas Assets in Malaysia to TotalEnergies
Austrian oil, gas and chemicals group OMV has signed an agreement to divest its 50% stake in Malaysia’s natural gas producer SapuraOMV Upstream to TotalEnergies for $903 million, including the transfer of a $350 million loan granted by OMV to SapuraOMV.
29.01.2024 • News
Corbion to Divest Emulsifiers Business to Kingswood
Dutch ingredients producer Corbion has agreed to divest its emulsifier business to US private equity firm Kingswood Capital Management for $362 million. The transaction, which is expected to close in the second quarter of this year, is contingent upon the satisfaction of certain conditions, including regulatory approvals.
23.01.2024 • News
Sanofi to Acquire Inhibrx for $1.7 Billion
Sanofi agreed to acquire biopharmaceutical company Inhibrx following the spin-off of non-INBRX-101 assets into New Inhibrx for approximately $1.7 billion and will also retain an 8% equity stake in New Inhibrx. Sanofi said that it expects to finance the transaction with available cash resources.
18.01.2024 • News
LyondellBasell to Acquire 35% of Saudi Arabia-based Natpet
LyondellBasell (LYB) has agreed to acquire a 35% stake in Saudi Arabia-based National Petrochemical Industrial Company (Natpet) from Alujain for approximately $500 million. Closing of the transaction is subject to regulatory and other customary closing conditions.
17.01.2024 • News
Italmatch Acquires the Majority of Brazil’s Alcolina
Italian specialty additives manufacturer Italmatch Chemicals agreed to purchase the majority of shares of Alcolina, a Brazilian chemicals company specialized in water treatment for bioethanol, sugar production and industrial applications. Financial details of the transaction were not disclosed.
17.01.2024 • News
Shell to Sell Nigeria Onshore Subsidiary for $1.3 Billion
Following its long-term goal of extracting itself from a challenging operating environment in the Niger Delta, Shell agreed to sell its Nigerian onshore subsidiary Shell Petroleum Development Company of Nigeria (SPDC) to Renaissance, a consortium of five companies comprising four exploration and production companies based in Nigeria and an international energy group, for $1.3 billion.
11.01.2024 • News
Altana Acquires Effect Pigments Producer Silberline
Global specialty chemicals group Altana has announced to acquire Silberline, a US company that specializes in developing and manufacturing aluminum effect pigments utilized in various applications, ranging from automotive coatings and printing inks to plastics, protective coatings, and packaged consumer goods.
10.01.2024 • News
GSK to Buy Respiratory Drug Developer Aiolos Bio
GSK has agreed to acquire biotech Aiolos Bio for a $1 billion upfront payment and up to $400 million for the achievement of certain milestones. Founded just last year, Aiolos is a San Francisco, USA and London, UK-based biopharmaceutical company that develops treatments for respiratory diseases.
09.01.2024 • News
Johnson & Johnson to Acquire Ambrx
Johnson & Johnson has entered into a definitive agreement to acquire Ambrx, a clinical-stage biopharmaceutical company with a proprietary synthetic biology technology platform to design and develop next-generation antibody-drug conjugates (ADCs). The all-cash merger transaction for a total equity value of approximately €1.8 billion ($2.0 billion), or €1.75 billion ($1.9 billion) net of estimated cash acquired.
09.01.2024 • News
Merck & Co. to Acquire Harpoon Therapeutics for $680 Million
US Merck & Co., known as MSD outside of North America, intends to buy cancer drug developer Harpoon Therapeutics for $23.00 per share in cash for an approximate equity value of $680 million.
05.01.2024 • News
Arcadium Lithium Emerges from Livent-Allkem Merger
Arcadium Lithium announced the completion of the all-stock merger of equals between Allkem and Livent. With roughly $1.9 billion of combined total revenue in 2022 and a global team of more than 2,600 employees, the new, combined company is one of the largest integrated producers of lithium chemicals.
04.01.2024 • News
AGI Acquires Flow Chemistry Specialist Chemtrix
Japan’s AGI Group, a producer of scientific precision glassware, has acquired flow chemistry company Chemtrix, based in Echt, the Netherlands. Chemtrix’s flow reactor portfolio delivers increased process safety, reduced operating costs and new chemical possibilities at scales ranging from milligrams in the lab through to tons for manufacturing.
03.01.2024 • News
Lilly Completes $1.4 Billion Acquisition of Point Biopharma
US drug manufacturer Eli Lilly has completed its acquisition of radiopharmaceutical company Point Biopharma for approximately $1.4 billion.
03.01.2024 • News
AstraZeneca to Buy Cell Therapy Developer Gracell for Up to $1.2 Billion
AstraZeneca has agreed to acquire Gracell Biotechnologies, a Chinese developer of cell therapies for the treatment of cancer and autoimmune diseases, for up to $1.2 billion. Only on Dec. 12, 2023, AstraZeneca announced that it was planning to acquire Icosavax for $1.2 billion.
28.12.2023 • News
Bristol Myers Squibb Acquires RayzeBio
Bristol Myers Squibb will acquire RayzeBio for a total equity value of approximately $4.1 billion, or $3.6 billion net of estimated cash acquired. The transaction was unanimously approved by both the Bristol Myers Squibb and RayzeBio Boards of Directors.
27.12.2023 • News
Barentz India Acquires Radian
Barentz has acquired Radian in India, reinforcing its product portfolio with color cosmetic ingredients. The move anticipates substantial growth in the Asia Pacific region. Radian's CEO, Manoj Botadra, and the current team will continue to manage operations, ensuring a smooth transition.
23.12.2023 • News
Bristol Myers Squibb Takes Over Karuna Therapeutics
Bristol Myers Squibb (BMS) and Karuna Therapeutics have entered into a definitive merger agreement under which the US drug maker has agreed to acquire the Boston-based biopharmaceutical company for a total equity value of $14.0 billion, or $12.7 billion net of estimated cash acquired. The transaction was unanimously approved by both the BMS and Karuna Boards of Directors.
20.12.2023 • News
Biosynth Acquires VIO Chemicals
Swiss Biosynth, a supplier of raw materials to the life science industry, has acquired VIO Chemicals, a Zurich, Switzerland-based company with leading chemical R&D expertise and a global network of large-scale manufacturing partners. Financial details of the transaction have not been disclosed.
19.12.2023 • News
OCI to Sell Iowa Fertilizer Stake to Koch for $3.6 Billion
Dutch fertilizer and industrial chemicals group OCI Global has agreed to sell 100% of its equity interests in its US nitrogen fertilizer facility Iowa Fertilizer Company (IFCO), located in Wever, Iowa, to Koch Ag & Energy Solutions (KAES) for $3.6 billion.
18.12.2023 • News
ADNOC to Acquire OCI’s Stake in Fertiglobe for $3.6 Billion
Abu Dhabi National Oil Company (ADNOC) has agreed to acquire OCI Global's entire majority stake in fertilizer producer Fertiglobe for $3.62 billion. Fertiglobe is a joint venture established in October 2019 between the state-owned oil company of the United Arab Emirates (UAE) and the Dutch fertilizer and industrial chemicals group.
18.12.2023 • News
Samyang Holdings Acquires Verdant Specialty Solutions
Samyang Holdings has acquired the management rights of the U.S.-based specialty chemical manufacturer Verdant Specialty Solutions from private equity firm OpenGate Capital. The total acquisition was approximately €230 million ($250 million).
14.12.2023 • News
AstraZeneca to Buy Vaccine Company Icosavax for $1.1 Billion
AstraZeneca has entered into an agreement to acquire Icosavax, a US biopharmaceutical company based in Seattle in a deal worth up to $1.1 billion. The company focuses on the development of differentiated vaccines with high potential using an innovative virus-like protein (VLP) particle platform.
07.12.2023 • News
AbbVie to Acquire Cerevel Therapeutics for $8.7 Billion
In a move to complement its neuroscience portfolio, US drugmaker AbbVie has agreed to acquire Cerevel Therapeutics, which has a pipeline of multiple clinical-stage and preclinical candidates with potential across several diseases including schizophrenia, Parkinson's disease (PD), and mood disorders.
06.12.2023 • News
Roche to Acquire Obesity Drug Maker Carmot
In a move to participate in the race for anti-obesity drugs, Swiss pharma giant Roche has agreed to acquire Carmot Therapeutics, a privately owned US company based in Berkeley, California.
05.12.2023 • News
Kemira Divests Oil and Gas Business to Sterling Specialty Chemicals
In a move to focus on its core businesses, Finnish chemicals company Kemira has signed an agreement to divest its oil and gas-related portfolio for €260 million to Sterling Specialty Chemicals, a US subsidiary of Artek Industries, a global industrial chemicals group based in India.
The Dow Chemical Company
Nova Chemicals
ICIG
Bio-Rad Laboratories
Evonik Industries AG
Covestro
Röhm GmbH
Medera
Managm. Consult. Chemicals
Immedica Pharma AB
BDP International
Brenntag SE
De Paauw Sustainable Resources (DPSR)
EvaluatePharma
Accenture
CSL Behring GmbH
KPMG AG Wirtschaftsprüfungsges.
Azelis Corporate Services NV
OneSource Specialty Pharma Limited
Barfeld & Partner GmbH
Royal DSM N.V.
Zeta GmbH
Johnson Matthey
Booz & Company
HAS Healthcare Advanced Synthesis SA
GlaxoSmithKline GmbH & Co. KG
Pricewaterhouse Coopers
CABB Group GmbH
H.B. Fuller Company
Kensing, LLC.
Honeywell International Inc.
DuPont Company
Ineos
Kemira Oyj
BASF SE
Solvay
LANXESS Deutschland GmbH
Merck & Co
Advancy GmbH
Squire Sanders
Archroma
Gilead Sciences, Inc.
Proventis Partners
DCAT - Drug, Chemical & Associated Technologies Association
Biogen Inc.
Aditya Birla Group
Infraserv GmbH & Co. Höchst KG
EuroAPI
Air Liquide Deutschland GmbH
PPG